Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
Add more filters










Publication year range
1.
Neurol Sci ; 2024 Apr 12.
Article in English | MEDLINE | ID: mdl-38607533

ABSTRACT

BACKGROUND: SPG18 is caused by mutations in the endoplasmic reticulum lipid raft associated 2 (ERLIN2) gene. Autosomal recessive (AR) mutations are usually associated with complicated hereditary spastic paraplegia (HSP), while autosomal dominant (AD) mutations use to cause pure SPG18. AIM: To define the variegate clinical spectrum of the SPG18 and to evaluate a dominant negative effect of erlin2 (encoded by ERLIN2) on oligomerization as causing differences between AR and AD phenotypes. METHODS: In a four-generation pedigree with an AD pattern, a spastic paraplegia multigene panel test was performed. Oligomerization of erlin2 was analyzed with velocity gradient assay in fibroblasts of the proband and healthy subjects. RESULTS: Despite the common p.V168M mutation identified in ERLIN2, a phenoconversion to amyotrophic lateral sclerosis (ALS) was observed in the second generation, pure HSP in the third generation, and a complicated form with psychomotor delay and epilepsy in the fourth generation. Erlin2 oligomerization was found to be normal. DISCUSSION: We report the first AD SPG18 family with a complicated phenotype, and we ruled out a dominant negative effect of V168M on erlin2 oligomerization. Therefore, our data do not support the hypothesis of a relationship between the mode of inheritance and the phenotype, but confirm the multifaceted nature of SPG18 on both genetic and clinical point of view. Clinicians should be aware of the importance of conducting an in-depth clinical evaluation to unmask all the possible manifestations associated to an only apparently pure SPG18 phenotype. We confirm the genotype-phenotype correlation between V168M and ALS emphasizing the value of close follow-up.

2.
Pharmaceuticals (Basel) ; 16(9)2023 Sep 14.
Article in English | MEDLINE | ID: mdl-37765110

ABSTRACT

The carbonic anhydrase isoform IX (hCAIX) is one of the main players in extracellular tumor pH regulation, and it is known to be overexpressed in breast cancer and other common tumors. hCA IX supports the growth and survival of tumor cells, and its expression is correlated with metastasis and resistance to therapies, making it an interesting biomarker for diagnosis and therapy. The aim of this work deals with the development of an MRI imaging probe able to target the extracellular non-catalytic proteoglycan-like (PG) domain of CAIX. For this purpose, a specific nanoprobe, LIP_PepC, was designed by conjugating a peptidic interactor of the PG domain on the surface of a liposome loaded with Gd-bearing contrast agents. A Mouse Mammary Adenocarcinoma Cell Line (TS/A) was chosen as an in vitro breast cancer model to test the developed probe. MRI results showed a high selectivity and sensitivity of the imaging probe toward hCAI-expressing TS/A cells. This approach appears highly promising for the in vivo translation of a diagnostic procedure based on the targeting of hCA IX enzyme expression.

3.
Cells ; 11(23)2022 Dec 02.
Article in English | MEDLINE | ID: mdl-36497151

ABSTRACT

Severe corneal damage leads to complete vision loss, thereby affecting life quality and impinging heavily on the healthcare system. Current clinical approaches to manage corneal wounds suffer from severe drawbacks, thus requiring the development of alternative strategies. Of late, mesenchymal stromal/stem cell (MSC)-derived extracellular vesicles (EVs) have become a promising tool in the ophthalmic field. In the present study, we topically delivered bone-marrow-derived MSC-EVs (BMSC-EVs), embedded in methylcellulose, in a murine model of alkali-burn-induced corneal damage in order to evaluate their role in corneal repair through histological and molecular analyses, with the support of magnetic resonance imaging. Our data show that BMSC-EVs, used for the first time in this specific formulation on the damaged cornea, modulate cell death, inflammation and angiogenetic programs in the injured tissue, thus leading to a faster recovery of corneal damage. These results were confirmed on cadaveric donor-derived human corneal epithelial cells in vitro. Thus, BMSC-EVs modulate corneal repair dynamics and are promising as a new cell-free approach for intervening on burn wounds, especially in the avascularized region of the eye.


Subject(s)
Corneal Injuries , Extracellular Vesicles , Mesenchymal Stem Cells , Animals , Humans , Mice , Bone Marrow , Extracellular Vesicles/metabolism , Mesenchymal Stem Cells/metabolism , Inflammation/metabolism , Corneal Injuries/therapy , Corneal Injuries/metabolism
4.
J Clin Med ; 10(2)2021 Jan 16.
Article in English | MEDLINE | ID: mdl-33467167

ABSTRACT

Ocular chemical and thermal burns are frequent causes of hospitalization and require immediate interventions and care. Various surgical and pharmacological treatment strategies are employed according to damage severity. Controlling inflammation and neovascularization while promoting normal ocular surface anatomy and function restoration is the principal aim. In the most severe cases, when epithelial healing is severely affected, reconstruction of the ocular surface may be a valid option, which, however, requires expertise, adequate instruments, and qualified donors. Numerous endogenous and exogenous strategies have been considered for corneal repair. Among these, stem cells and their derivatives have offered numerous attractive possibilities in finding an effective way in stimulating corneal regeneration. Limbal epithelial stem cells and mesenchymal cells from the ocular tissue as well as from various sources have demonstrated their effectiveness in dampening neovascularization, scarring, and inflammation, while promoting epithelialization of the injured cornea. Moreover, a plethora of cytokines and growth factors, and extracellular vesicles, which constitute the secretome of these cells, work in concert to enhance wound healing. In this review, we provide an update on the recent potential therapeutic avenues and clinical applications of stem cells and their products in corneal regeneration after burn injury, as well as current imaging strategies for monitoring therapeutic efficacy and damage resolution.

5.
Org Lett ; 20(23): 7478-7482, 2018 12 07.
Article in English | MEDLINE | ID: mdl-30427200

ABSTRACT

A one-pot, high-yield procedure for synthesizing lanthionine-containing peptides was developed. It relies on the S-alkylation of cysteine-containing peptides with chiral cyclic sulfamidates. The key feature of this approach is the use of mild reaction conditions (only activated molecular sieves are employed as the catalyst), leading to good chemoselectivity and excellent stereochemical control. The potential of the new methodology has been investigated by synthesizing the thioether ring of a natural lantibiotic, Haloduracin ß.


Subject(s)
Alanine/analogs & derivatives , Peptides/chemical synthesis , Sulfides/chemistry , Sulfonic Acids/chemistry , Alanine/chemistry , Alkylation , Molecular Conformation , Peptides/chemistry
6.
Chemistry ; 24(23): 6231-6238, 2018 Apr 20.
Article in English | MEDLINE | ID: mdl-29457654

ABSTRACT

An efficient and rapid procedure for synthesizing S-linked glycopeptides is reported. The approach uses activated molecular sieves as a base to promote the selective S-alkylation of readily prepared cysteine-containing peptides, upon reaction of appropriate glycosyl halides. Considering the very mild conditions employed, the chemoselective linkage of the electrophilic sugar with a peptide sulfhydryl group occurred in satisfactory yield, allowing the incorporation of mono and disaccharide moieties. The sugar-peptide conjugates obtained from α-d-glycosyl derivatives adopt a ß-S-configuration, indicating the high stereoselectivity of the substitution reaction.


Subject(s)
Peptides/chemistry , Alkylation , Glycopeptides/chemistry , Glycosylation , Molecular Structure
8.
Neurogenetics ; 13(3): 195-203, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22526352

ABSTRACT

Inherited disorders characterized by motor neuron loss and muscle weakness are genetically heterogeneous. The recent identification of mutations in the gene encoding transient receptor potential vanilloid 4 (TRPV4) in distal spinal muscular atrophy (dSMA) prompted us to screen for TRPV4 mutations in a small group of children with compatible phenotype. In a girl with dSMA and vocal cord paralysis, we detected a new variant (p.P97R) localized in the cytosolic N-terminus of the TRPV4 protein, upstream of the ankyrin-repeat domain, where the great majority of disease-associated mutations reside. In another child with congenital dSMA, in this case associated with bone abnormalities, we detected a previously reported mutation (p.R232C). Functional analysis of the novel p.P97R mutation in a heterologous system demonstrated a loss-of-function mechanism. Protein localization studies in muscle, skin, and cultured skin fibroblasts from both patients showed normal protein expression. No TRPV4 mutations were detected in four children with dSMA without bone or vocal cord involvement. Adding to the clinical and molecular heterogeneity of TRPV4-associated diseases, our results suggest that molecular testing of the TRPV4 gene is warranted in cases of congenital dSMA with bone abnormalities and vocal cord paralysis.


Subject(s)
Muscular Atrophy, Spinal/genetics , Mutation , TRPV Cation Channels/genetics , Adult , Child , Child, Preschool , Female , Fibroblasts/cytology , Fibroblasts/metabolism , Genetic Variation , Genotype , Humans , Introns , Male , Muscular Atrophy, Spinal/congenital , Pedigree , Phenotype , Vocal Cord Paralysis/pathology
9.
Contrast Media Mol Imaging ; 7(2): 175-84, 2012.
Article in English | MEDLINE | ID: mdl-22434630

ABSTRACT

Two novel Gd-based contrast agents (CAs) for the molecular imaging of matrix metalloproteinases (MMPs) were synthetized and characterized in vitro and in vivo. These probes were based on the PLG*LWAR peptide sequence, known to be hydrolyzed between Gly and Leu by a broad panel of MMPs. A Gd-DOTA chelate was conjugated to the N-terminal position through an amide bond, either directly to proline (compd Gd-K11) or through a hydrophilic spacer (compd Gd-K11N). Both CA were made strongly amphiphilic by conjugating an alkyl chain at the C-terminus of the peptide sequence. Gd-K11 and Gd-K11N have a good affinity for ß-cyclodextrins (K(D) 310 and 670 µ m respectively) and for serum albumin (K(D) 350 and 90 µ m respectively), and can be efficiently cleaved in vitro at the expected site by MMP-2 and MMP-12. Upon MMP-dependent cleavage, the CAs lose the C-terminal tetrapeptide and the alkyl chain, thus undergoing to an amphiphilic-to-hydrophilic transformation that is expected to alter tissue pharmacokinetics. To prove this, Gd-K11 was systemically administered to mice bearing a subcutaneous B16.F10 melanoma, either pre-treated or not with the broad spectrum MMP inhibitor GM6001 (Ilomastat). The washout of the Gd-contrast enhancement in MR images was significantly faster for untreated subjects (displaying MMP activity) with respect to treated ones (MMP activity inhibited). The washout kinetics of Gd-contrast enhancement from the tumor microenvironment could be then interpreted in terms of the local activity of MMPs.


Subject(s)
Gadolinium , Matrix Metalloproteinases/metabolism , Molecular Imaging/methods , Molecular Probes/metabolism , Animals , Chromatography, High Pressure Liquid , Chromatography, Reverse-Phase , Disease Models, Animal , Gadolinium/chemistry , Magnetic Resonance Spectroscopy , Male , Mass Spectrometry , Melanoma/enzymology , Melanoma/pathology , Mice , Mice, Inbred C57BL , Solid-Phase Synthesis Techniques
10.
Mol Pharm ; 8(5): 1750-6, 2011 Oct 03.
Article in English | MEDLINE | ID: mdl-21780833

ABSTRACT

Murine melanoma B16 cells display on the extracellular side of the plasma membrane a large number of reactive protein thiols (exofacial protein thiols, EPTs). These EPTs can be chemically labeled with Gd-DO3A-PDP, a Gd(III)-based MRI contrast agent bearing a 2-pyridinedithio chemical function for the recognition of EPTs. Uptake of gadolinium up to 10(9) Gd atoms per cell can be achieved. The treatment of B16 cells ex vivo with a reducing agent such as tris(2-carboxyethyl)phosphine (TCEP) results in an increase by 850% of available EPTs and an increase by 45% of Gd uptake. Blocking EPTs with N-ethylmaleimide (NEM) caused a decrease by 84% of available EPTs and a decrease by 55% of Gd uptake. The amount of Gd taken up by B16 cells is therefore dependent upon the availability of EPTs, whose actual level in turn changes according to the extracellular redox microenvironment. Then Gd-DO3A-PDP has been assessed for the labeling of tumor cells in vivo on B16.F10 melanoma tumor-bearing mice. Gd-DO3A-PDP (or Gd-DO3A as the control) has been injected directly into the tumor region at a dose level of 0.1 µmol and the signal enhancement in MR images followed over time. The washout kinetics of Gd-DO3A-PDP from tumor is very slow if compared to that of control Gd-DO3A, and 48 h post injection, the gadolinium-enhancement is still clearly visible. Therefore, B16 cells can be labeled ex vivo as well as in vivo according to a common EPTs-dependent route, provided that high levels of the thiol reactive probe can be delivered to the tumor.


Subject(s)
Contrast Media , Coordination Complexes , Gadolinium , Melanoma, Experimental/diagnosis , Sulfhydryl Reagents , Sulfides , Animals , Biological Transport/drug effects , Cell Line, Tumor , Contrast Media/administration & dosage , Contrast Media/chemistry , Coordination Complexes/administration & dosage , Coordination Complexes/chemistry , Gadolinium/administration & dosage , Gadolinium/chemistry , Injections, Intralesional , Kinetics , Ligands , Limit of Detection , Magnetic Resonance Imaging , Male , Melanoma, Experimental/metabolism , Melanoma, Experimental/pathology , Mice , Mice, Inbred C57BL , N-Ethylmaleimide-Sensitive Proteins/chemistry , N-Ethylmaleimide-Sensitive Proteins/metabolism , Pyridines/chemistry , Sulfhydryl Reagents/administration & dosage , Sulfhydryl Reagents/chemistry , Sulfhydryl Reagents/pharmacology , Sulfides/chemistry
11.
Chem Commun (Camb) ; 47(16): 4667-9, 2011 Apr 28.
Article in English | MEDLINE | ID: mdl-21409237

ABSTRACT

A novel class of paramagnetic liposome-based systems acting as dual T(1) and CEST (1)H-MRI contrast agents is described. The vesicles contain a shift reagent in the aqueous core and a Gd-complex on the external surface conjugated through a biodegradable linker. As such, the probe can generate T(1) contrast only, but after the cleavage and removal of the Gd-coating, the CEST contrast is switched on.


Subject(s)
Contrast Media/chemistry , Gadolinium/chemistry , Liposomes/chemistry , Magnetic Resonance Imaging , Molecular Probes/chemistry , Organometallic Compounds/chemistry , Magnetics , Molecular Structure , Protons
12.
J Med Chem ; 53(13): 4877-90, 2010 Jul 08.
Article in English | MEDLINE | ID: mdl-20533827

ABSTRACT

Four novel MRI Gd(III)-based probes have been synthesized and evaluated for their labeling properties on cultured cell lines K562, C6, and B16. The labeling strategy relies upon the fact that cells display a large number of reactive exofacial protein thiols (EPTs) that can be exploited as anchorage points for suitably activated MRI probes. The probes are composed of a Gd(III) chelate (based on either DO3A or DTPA) connected through a flexible linker to the 2-pyridyldithio chemical function for binding to EPTs. GdDO3A-based chelates could efficiently label cells (up to a level of 1.2 x 10(10) Gd(III) atoms/cell), whereas GdDTPA-based chelates showed poor or no cell labeling ability at all. Among the GdDO3A based compounds, that having the longest spacer (compound GdL1A) showed the best labeling efficacy. The mechanism of EPT mediated cell labeling by GdL1A involves probe internalization without sequestration of the Gd(III) chelate within subcellular structures such as endosomes.


Subject(s)
Gadolinium/chemistry , Organometallic Compounds/chemistry , Organometallic Compounds/pharmacokinetics , Proteins/metabolism , Sulfhydryl Compounds/metabolism , Animals , Chelating Agents/chemical synthesis , Chelating Agents/chemistry , Chelating Agents/pharmacokinetics , Contrast Media/chemical synthesis , Contrast Media/chemistry , Contrast Media/pharmacokinetics , Glioma/metabolism , Humans , K562 Cells , Magnetic Resonance Imaging/methods , Magnetic Resonance Spectroscopy , Melanoma, Experimental/metabolism , Mice , Organometallic Compounds/chemical synthesis , Proteins/chemistry , Rats , Spectrophotometry, Ultraviolet , Sulfhydryl Compounds/chemistry
14.
Exp Cell Res ; 315(2): 285-303, 2009 Jan 15.
Article in English | MEDLINE | ID: mdl-18992740

ABSTRACT

KRIT1 is a disease gene responsible for Cerebral Cavernous Malformations (CCM). It encodes for a protein containing distinct protein-protein interaction domains, including three NPXY/F motifs and a FERM domain. Previously, we isolated KRIT1B, an isoform characterized by the alternative splicing of the 15th coding exon and suspected to cause CCM when abnormally expressed. Combining homology modeling and docking methods of protein-structure and ligand binding prediction with the yeast two-hybrid assay of in vivo protein-protein interaction and cellular biology analyses we identified both structural and functional differences between KRIT1A and KRIT1B isoforms. We found that the 15th exon encodes for the distal beta-sheet of the F3/PTB-like subdomain of KRIT1A FERM domain, demonstrating that KRIT1B is devoid of a functional PTB binding pocket. As major functional consequence, KRIT1B is unable to bind Rap1A, while the FERM domain of KRIT1A is even sufficient for this function. Furthermore, we found that a functional PTB subdomain enables the nucleocytoplasmic shuttling of KRIT1A, while its alteration confers a restricted cytoplasmic localization and a dominant negative role to KRIT1B. Importantly, we also demonstrated that KRIT1A, but not KRIT1B, may adopt a closed conformation through an intramolecular interaction involving the third NPXY/F motif at the N-terminus and the PTB subdomain of the FERM domain, and proposed a mechanism whereby an open/closed conformation switch regulates KRIT1A nuclear translocation and interaction with Rap1A in a mutually exclusive manner. As most mutations found in CCM patients affect the KRIT1 FERM domain, the new insights into the structure-function relationship of this domain may constitute a useful framework for understanding molecular mechanisms underlying CCM pathogenesis.


Subject(s)
Central Nervous System Vascular Malformations/physiopathology , Hemangioma, Cavernous, Central Nervous System/physiopathology , Microtubule-Associated Proteins/physiology , Protein Interaction Domains and Motifs/physiology , Proto-Oncogene Proteins/physiology , Animals , COS Cells , Cell Line , Central Nervous System Vascular Malformations/genetics , Chlorocebus aethiops , Computer Simulation , HeLa Cells , Hemangioma, Cavernous, Central Nervous System/genetics , Humans , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , KRIT1 Protein , Mice , Microfilament Proteins/genetics , Microfilament Proteins/metabolism , Microtubule-Associated Proteins/chemistry , Microtubule-Associated Proteins/genetics , Models, Molecular , Peptide Fragments/chemistry , Peptide Fragments/genetics , Peptide Fragments/metabolism , Point Mutation , Protein Binding , Protein Interaction Domains and Motifs/genetics , Protein Isoforms/chemistry , Protein Isoforms/genetics , Protein Isoforms/physiology , Protein Structure, Secondary , Proto-Oncogene Proteins/chemistry , Proto-Oncogene Proteins/genetics , Rats , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Two-Hybrid System Techniques , rap1 GTP-Binding Proteins/chemistry , rap1 GTP-Binding Proteins/genetics , rap1 GTP-Binding Proteins/metabolism
15.
Proteins ; 71(4): 1721-31, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18076040

ABSTRACT

Recent mutagenic and molecular modelling studies suggested a role for glycine 84 in the putative oxyanion loop of the carboxylesterase EST2 from Alicyclobacillus acidocaldarius. A 114 times decrease of the esterase catalytic activity of the G84S mutant was observed, without changes in the thermal stability. The recently solved three-dimensional (3D) structure of EST2 in complex with a HEPES molecule permitted to demonstrate that G84 (together with G83 and A156) is involved in the stabilization of the oxyanion through a hydrogen bond from its main chain NH group. The structural data in this case did not allowed us to rationalize the effect of the mutation, since this hydrogen bond was predicted to be unaltered in the mutant. Since the mutation could shed light on the role of the oxyanion loop in the HSL family, experiments to elucidate at the mechanistic level the reasons of the observed drop in k (cat) were devised. In this work, the kinetic and structural features of the G84S mutant were investigated in more detail. The optimal temperature and pH for the activity of the mutated enzyme were found significantly changed (T = 65 degrees C and pH = 5.75). The catalytic constants K (M) and V(max) were found considerably altered in the mutant, with ninefold increased K (M) and 14-fold decreased V(max), at pH 5.75. At pH 7.1, the decrease in k (cat) was much more dramatic. The measurement of kinetic constants for some steps of the reaction mechanism and the resolution of the mutant 3D structure provided evidences that the observed effects were partly due to the steric hindrance of the S84-OH group towards the ester substrate and partly to its interference with the nucleophilic attack of a water molecule on the second tetrahedral intermediate.


Subject(s)
Carboxylic Ester Hydrolases/chemistry , Carboxylic Ester Hydrolases/metabolism , Gram-Positive Endospore-Forming Rods/enzymology , Binding Sites , Carboxylic Ester Hydrolases/genetics , Catalysis , Crystallography, X-Ray , Enzyme Stability , Glycine/chemistry , Glycine/metabolism , Hydrogen Bonding , Hydrogen-Ion Concentration , Hydrolysis , Kinetics , Models, Molecular , Mutation , Protein Binding , Protein Structure, Secondary , Serine/chemistry , Serine/metabolism , Substrate Specificity , Temperature , Water/chemistry , X-Ray Diffraction
17.
Bioorg Med Chem Lett ; 16(24): 6204-8, 2006 Dec 15.
Article in English | MEDLINE | ID: mdl-17000110

ABSTRACT

The X-ray crystal structures of 5-amino-1,3,4-thiadiazole-2-sulfonamide (the acetazolamide precursor) and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide in complex with the human isozyme II of carbonic anhydrase (CA, EC 4.2.1.1) are reported. The thiadiazole-sulfonamide moiety of the two compounds binds in the canonic manner to the zinc ion and interacts with Thr199, Glu106, and Thr200. The substituted phenyl tail of the second inhibitor was positioned in the hydrophobic part of the binding pocket, at van der Waals distance from Phe131, Val 135, Val141, Leu198, Pro202, and Leu204. These structures may help in the design of better inhibitors of these widespread zinc-containing enzymes.


Subject(s)
Carbonic Anhydrase Inhibitors/chemistry , Carbonic Anhydrases/metabolism , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Sulfonamides/pharmacokinetics , Thiadiazoles/pharmacokinetics , Carbonic Anhydrase Inhibitors/pharmacokinetics , Crystallography, X-Ray , Enzyme Inhibitors/pharmacokinetics , Models, Molecular , Molecular Conformation , Structure-Activity Relationship , Sulfonamides/chemistry , Thiadiazoles/chemistry
18.
J Med Chem ; 48(18): 5721-7, 2005 Sep 08.
Article in English | MEDLINE | ID: mdl-16134940

ABSTRACT

Structure for the adduct of carbonic anhydrase II with 1-N-(4-sulfamoylphenyl-ethyl)-2,4,6-trimethylpyridinium perchlorate, a membrane-impermeant antitumor sulfonamide, is reported. The phenylethyl moiety fills the active site, making van der Waals interactions with side chains of Gln192, Val121, Phe131, Leu198, Thr200. The 2,4,6-trimethylpyridinium functionality is at van der Waals distance from the aliphatic chain of Ile91 being involved in strong offset face-to-face stacking with Phe131. Analyzing X-ray crystal structures of such adducts, two binding modes were observed: some inhibitors bind with their tail within the hydrophobic half of the active site, defined by residues Phe131, Val135, Leu198, Pro202, Leu204. Other derivatives bind with their tail in a different region, pointing toward the hydrophilic half and making strong parallel stacking with Phe131. This interaction orients the inhibitor toward the hydrophilic part of the active site. Impossibility to participate in it leads to its binding within the hydrophobic half. Such findings are relevant for designing better inhibitors targeting isozymes II, IX, and XII, some of which are overexpressed in hypoxic tumors.


Subject(s)
Antineoplastic Agents/chemistry , Carbonic Anhydrase II/antagonists & inhibitors , Carbonic Anhydrase II/chemistry , Pyridinium Compounds/chemistry , Sulfonamides/chemistry , Antigens, Neoplasm/chemistry , Binding Sites , Biomarkers, Tumor/chemistry , Carbonic Anhydrase IX , Carbonic Anhydrases/chemistry , Cell Membrane Permeability , Crystallography, X-Ray , Humans , Isoenzymes/antagonists & inhibitors , Isoenzymes/chemistry , Models, Molecular , Molecular Structure , Protein Binding , Quantitative Structure-Activity Relationship , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/chemistry
20.
Bioorg Med Chem Lett ; 15(9): 2315-20, 2005 May 02.
Article in English | MEDLINE | ID: mdl-15837316

ABSTRACT

The antiepileptic drug zonisamide was considered to act as a weak inhibitor of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1) (with a K(I) of 4.3 microM against the cytosolic isozyme II). Here we prove that this is not true. Indeed, testing zonisamide in the classical assay conditions of the CO2 hydrase activity of hCA II, with incubation times of enzyme and inhibitor solution of 15 min, a K(I) of 10.3 microM has been obtained. However, when the incubation between enzyme and inhibitor was prolonged to 1 h, the obtained K(I) was of 35.2 nM, of the same order of magnitude as that of the clinically used sulfonamides/sulfamates acetazolamide, methazolamide, ethoxzolamide and topiramate (K(I)s in the range of 5.4-15.4 nM). The inhibition of the human mitochondrial isozyme hCA V with these compounds has been also tested by means of a dansylamide competition binding assay, which showed zonisamide and topiramate to be effective inhibitors, with K(I)s in the range of 20.6-25.4 nM. The X-ray crystal structure of the adduct of hCA II with zonisamide has also been solved at a resolution of 1.70 A, showing that the sulfonamide moiety participates in the classical interactions with the Zn(II) ion and the residues Thr199 and Glu106, whereas the benzisoxazole ring is oriented toward the hydrophobic half of the active site, establishing a large number of strong van der Waals interactions (<4.5 A) with residues Gln92, Val121, Phe131, Leu198, Thr200, Pro202.


Subject(s)
Carbonic Anhydrase II/chemistry , Carbonic Anhydrase II/metabolism , Carbonic Anhydrase Inhibitors/pharmacology , Carbonic Anhydrase V/chemistry , Carbonic Anhydrase V/metabolism , Isoxazoles/pharmacology , Binding Sites , Carbonic Anhydrase Inhibitors/chemistry , Crystallography, X-Ray , Cytosol/enzymology , Humans , Isoxazoles/chemistry , Kinetics , Mitochondria/enzymology , Models, Molecular , Protein Conformation , Zonisamide
SELECTION OF CITATIONS
SEARCH DETAIL
...